CanAdelaar

CanAdelaar is a Netherlands-based pharmaceutical company specializing in the development, production, and distribution of GMP-certified cannabinoid-based active pharmaceutical ingredients (APIs) and finished medicinal products. The company bridges the gap between the cannabis industry and traditional healthcare by providing standardized, science-backed cannabinoid solutions for indications such as chronic pain and neurological disorders. CanAdelaar offers a range of services including contract manufacturing (CMO) and research and development for cannabinoid therapeutics, ensuring high purity and consistency for clinical use. Operating with a pharmacy-first philosophy, the company aims to integrate medical cannabis into mainstream healthcare through rigorous quality standards and professional distribution. Their product portfolio includes high-purity CBD and THC extracts used in various therapeutic applications across Europe.